A history of the use of AMS in GSK studies spanning the last 8 years will be presented, including use in pilot studies through to clinical, animal and in vitro studies. A brief summary of the status of GSK's in-house AMS capability will be outlined and views on the future of AMS in GSK will be presented including potential impact on drug development and potential advances in AMS technology.
See more of AMS in Low Dose Bioscience Workshop
See more of The 10th International Conference on Accelerator Mass Spectrometry (September 5-10, 2005)